Shares of major biotech companies stumbled Friday on concerns the sector may be overheated. The iShares NASDAQ …
A 1-for-20 reverse stock split was implemented on January 26, 2018. Clinical Trials & Near-term Catalysts: The lead drug candidate is M207 for the treatment of migraine. A long-term safety study of M207 is underway. -- The Company …
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering. There can be no …
Some of the more unusual items included enough to stock a small medical clinic: blood vials, dentures, a knee brace, pill bottles, a surgical mask, and a bottle of …
The 2012 SandHills Stock Show & Rodeo Director Angie Bryant, President Bill Wight and Vice President Kevin Evans presented scholarships to the 2012 Miss Rodeo SandHills Ashley Buffington, Miss Rodeo SandHills Teen Carlie Porter …
CHICAGO, April 9, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACAD, DB, GM, NVS, …
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company …
This same crowd, made rich and especially stupid by the stock market boom, has no problem with the endless suffering …
wsws1mon
and consultants had focused on satisfying routine regulatory requirements for the dam — which anchors a water system that supplies more than half of California's people — but never took stock of whether the dam complex was built well …
Who is doing stories about the lives of registered nurses, waiters and waitresses, customer service representatives, janitors and cleaners, laborers and freight, stock and material movers, and secretaries and administrative …